Back to Search
Start Over
Multicenter, noncomparative study of caspofungin in combination with other antifungals as salvage therapy in adults with invasive aspergillosis.
- Source :
- Cancer, 107 (12
- Publication Year :
- 2006
-
Abstract
- Caspofungin inhibits synthesis of beta-1,3-glucan, an essential component of the Aspergillus cell wall. This echinocandin has demonstrated efficacy (45% success) as salvage monotherapy of invasive aspergillosis (IA). Interest remains as to whether caspofungin, in combination with other antifungal classes, can improve the efficacy against IA.<br />Clinical Trial<br />Journal Article<br />Multicenter Study<br />Research Support, Non-U.S. Gov't<br />FLWIN<br />info:eu-repo/semantics/published
Details
- Database :
- OAIster
- Journal :
- Cancer, 107 (12
- Notes :
- 1 full-text file(s): application/pdf, English
- Publication Type :
- Electronic Resource
- Accession number :
- edsoai.ocn803503148
- Document Type :
- Electronic Resource